CORE CARE FAMILY PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: B81663 | GRIMSBY, DN31 2BH
Showing results 101-150 of 377
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Olanzapine | 129 | 2,941 | £814 | -65.2% ▼ |
| Mesalazine (Systemic) | 127 | 12.9K | £6.0K | -47.0% ▼ |
| Hyoscine butylbromide | 126 | 7,397 | £650 | -45.9% ▼ |
| Promethazine hydrochloride | 125 | 5,309 | £504 | -65.0% ▼ |
| Diclofenac diethyl | 122 | 12.1K | £579 | -65.6% ▼ |
| Beclometasone dipropionate | 117 | 121 | £365 | -45.6% ▼ |
| 117 | 18.6K | £1.0K | -75.3% ▼ | |
| 117 | 58.2K | £802 | -55.7% ▼ | |
| Memantine hydrochloride | 115 | 2,156 | £235 | -65.2% ▼ |
| Estradiol | 115 | 12.2K | £1.7K | -86.0% ▼ |
| Aripiprazole | 111 | 2,597 | £504 | -56.4% ▼ |
| Insulin degludec | 111 | 531 | £5.3K | +1.0% vs avg |
| Sumatriptan succinate | 108 | 867 | £286 | -69.5% ▼ |
| Semaglutide | 107 | 1,313 | £9.3K | -55.6% ▼ |
| Fentanyl | 104 | 1,030 | £2.8K | +1.5% vs avg |
| Mirabegron | 104 | 3,200 | £2.9K | -74.1% ▼ |
| Linagliptin | 103 | 2,219 | £2.5K | -74.9% ▼ |
| Sulfasalazine | 102 | 8,218 | £1.2K | -21.6% ▼ |
| Budesonide | 99 | 116 | £2.9K | -81.7% ▼ |
| Combined ethinylestradiol 30mcg | 99 | 7,236 | £439 | -64.4% ▼ |
| Docusate sodium | 98 | 2,920 | £217 | -73.6% ▼ |
| Insulin aspart | 97 | 470 | £3.2K | -74.5% ▼ |
| Betamethasone valerate | 97 | 6,620 | £512 | -74.8% ▼ |
| Thiamine hydrochloride | 96 | 4,842 | £129 | -81.8% ▼ |
| Enalapril maleate | 93 | 8,028 | £694 | -48.2% ▼ |
| Alogliptin | 93 | 3,059 | £2.8K | -63.3% ▼ |
| Amisulpride | 90 | 1,260 | £259 | +28.0% ▲ |
| Esomeprazole | 88 | 1,988 | £109 | -78.3% ▼ |
| Topiramate | 88 | 2,794 | £1.1K | -50.5% ▼ |
| Biphasic insulin aspart | 88 | 500 | £3.0K | -13.3% ▼ |
| Warfarin sodium | 87 | 7,492 | £242 | -81.6% ▼ |
| Tiotropium bromide | 86 | 410 | £2.0K | -71.7% ▼ |
| Hydroxychloroquine sulfate | 86 | 4,846 | £215 | -55.6% ▼ |
| Oxybutynin | 83 | 3,996 | £626 | -56.4% ▼ |
| Other multivitamin preparations | 83 | 2,436 | £748 | -52.0% ▼ |
| Methotrexate | 83 | 2,096 | £125 | -74.5% ▼ |
| Pizotifen malate | 82 | 1,883 | £93 | -0.5% vs avg |
| Co-careldopa (Carbidopa/levodopa) | 81 | 12.2K | £1.1K | -64.2% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 80 | 6,288 | £269 | -73.9% ▼ |
| 79 | 520 | £281 | -22.7% ▼ | |
| Hydrocortisone | 78 | 2,130 | £341 | -82.6% ▼ |
| Perindopril erbumine | 77 | 2,934 | £267 | -85.5% ▼ |
| Bimatoprost | 77 | 1,278 | £712 | -48.2% ▼ |
| 77 | 11.0K | £1.6K | +97.8% ▲ | |
| Fluticasone furoate/vilanterol | 75 | 81 | £1.7K | -51.6% ▼ |
| Calcipotriol | 75 | 10.4K | £5.8K | -55.9% ▼ |
| Cyclizine hydrochloride | 74 | 4,157 | £145 | -54.1% ▼ |
| Levetiracetam | 74 | 5,248 | £355 | -83.8% ▼ |
| Estradiol with progestogen | 72 | 3,310 | £1.4K | -78.9% ▼ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 71 | 9,144 | £577 | -60.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.